The document is a comprehensive career summary for Ayush Jain, compiled in June 2023. It outlines his multidisciplinary professional identity as a former venture capitalist, product manager, global marketer, and biomedical engineer. The summary details his tenure at Revolution’s Rise of the Rest Seed Fund (2020‑2023), where he progressed from Venture Fellow to Vice President and Venture Advisor, sourced and diligenced deals, and deployed over $20 M into 19 early‑stage companies across healthcare, AI/ML, consumer software, logistics, and climate sectors. It enumerates the portfolio companies he led or supported, providing URLs for each. The narrative then shifts to his product and R&D leadership at Stryker (2016‑2019), highlighting flagship projects such as the drug‑coated stent “Mystique,” the flow diverters “Surpass Evolve” and “Surpass Streamline,” a brand‑refresh for neurovascular balloon catheters, and the innovative implant “Citadel,” noting clinical trial status, internal investment amounts (e.g., $100 M+ for Mystique), revenue potential, and multiple Stryker Team Innovation Awards. Prior experience at Johnson & Johnson (2013‑2016) includes technical leadership on the SMART Control stent system and a novel implant for May‑Thurner Syndrome. Earlier academic work as a Harvard‑MIT Health Sciences & Technology research fellow involved developing a “Heart‑On‑A‑Chip.” Volunteer leadership at Minds Matter San Francisco is described, where he mentored and co‑presided over a 300‑volunteer education nonprofit. The summary concludes with education credentials (MBA from Georgetown, B.S. in Biomedical Engineering from Boston University) and a performance metric of 92 % YoY fundraising growth, raising over $1 M while improving gross margins. Throughout, the document emphasizes quantitative impact, cross‑functional leadership, and a track record of translating technical innovation into market‑ready medical solutions.
Topics
Multidisciplinary Professional Identity & Career Narrative
An overview of Ayush Jain’s diverse background spanning venture capital, product management, global marketing, and biomedical engineering.
Venture Capital Leadership at Revolution (Rise of the Rest Seed Fund)
Roles from Venture Fellow to Vice President, responsibilities in sourcing, diligence, closing, and portfolio support, managing a $300 M fund and deploying $20 M+ into 19 early‑stage companies.
Portfolio Companies Categorized by Sector
List of invested companies across Healthcare, AI/ML, Consumer Software, Logistics, and Climate, each with company name, location, and hyperlink.
Product & Market Leadership at Stryker
Key product initiatives: Mystique drug‑coated stent, Surpass Evolve and Streamline flow diverters, neurovascular balloon catheter brand refresh, and Citadel implant; includes market research, clinical trial involvement, global launch strategy, and internal investment figures.
Technical Innovation & Intellectual Property at Stryker
Invention of novel design elements, advanced chemical etching process for Nitinol‑Platinum implants, root‑cause analysis for Citadel, and receipt of Stryker Team Innovation Awards (2016, 2017).
Johnson & Johnson R&D Contributions
Technical lead on SMART Control vascular stent system, development of next‑generation peripheral artery disease delivery system, and novel implant for May‑Thurner Syndrome, generating $50 M+ global revenue.
Academic Research Fellowship (Harvard‑MIT HST)
Research and development of a Heart‑On‑A‑Chip platform, published work, and interdisciplinary training.
Volunteer Leadership at Minds Matter San Francisco
Mentor and Co‑President role overseeing 300+ volunteers, managing 14+ team members, and impacting low‑income high‑achieving high school students.